Leptomycin B Increases Radiosensitization by Trichostain A in HeLa Cells

국문 초록 (Abstract)

목 적: 히스톤탈아세틸화효소 억제제는 그 자체의 항암효과뿐만 아니라 방사선 감작제로서의 효과가 점차 분명해져가고 있다. 최근 Class I 특이적인 히스톤탈아세틸화효소 억제제의 개발로 계층 특이적인(class specific) 연구가 가능해짐에 따라, 본 연구에서는 서로 다른 히스톤탈아세틸화효소억제제의 방사선감작효과를 비교함과 동시에 p53 발현도의 차이가 히스톤탈아세틸화효소억제제의 방사선 감수성에 미치는 영향을 알아보고자 하였다. 대상 및 방법: 이를 위해 p53 발현도가 매우 낮은 HeLa 세포에 p53의 핵 외 수송을 억제하여 세포질 내 분해를 차단하는 Leptomycin B를 처리하여 p53의 발현도를 현저하게 높인 후, Trichostatin와 SK7041의 방사선 민감도를 비교 관찰하였다. 결 과: 세포생존곡선, SER 및 SF2를 비교 분석 시, p53의 발현이 높은 Leptomycin B 처리군에서 TrichostatinA가 Class I HDAC만을 억제하는 SK7041에 비해 유의하게 높은 방사선 감작효과를 나타내었다. 이는 p53이 Class I 특이적 억제제인 SK7041과 Class I과 II를 모두 억제하는 TSA의 방사선감작효과에 미치는 영향의 차이에 기전적으로 관여함을 시사한다. 결 론: Leptomycin B에 의해 유도된 p53의 발현증가는 Class I과 Class I과 II를 모두 억제하는 TSA의 방사선 감작효과를 증강시킨다.

다국어 초록 (Multilingual Abstract)

Purpose: Histone deacetylase inhibitors (HDIs) are emerging as potentially useful components of anticancer therapy and their radiosensitizing effects have become evident. Specific HDIs are now available that preferentially inhibit specific HDAC classes; TSA inhibits Class I and II HDACs, and SK7041 inhibits Class I HDACs. Materials and Methods: We tested the differential radiosensitization induced by two different classes of HDIs in HeLa cells. We next tested the hypothesis that p53 expression in cancer cells may influence the susceptibility to HDIs by using pharmacologic modification of the p53 status under an isogenic background. Results: It is interesting that p53 expression in the HeLa cells clearly increased the degree of radiosensitization by TSA compared to that of the class I specific inhibitor SK7041. This suggests that p53 may, in part, be responsible for the mechanistic role for the greater radiosensitization induced by Class I & II inhibitors compared to that of the class I specific inhibitors. Thus, these studies are useful in distinguishing between events mediated solely by the Class I HDACs versus those events involving the other classes of HDACs as well. Conclusion: The anticancer efficacy of targeting Class I and II HDACs, in conjunction with radiation therapy, may be further enhanced by the restoration of p53 expression.

목차 (Table of Contents)

• Introduction Materials and Methods Results Discussion

참고문헌 (Reference)

1 "potentiated cytotoxic effect of inonizing radiation in human head and neck cancer cell lines" 22 : 138-144, 2004

2 "p53 sites acetylated in vitro by PCAF and p300 are acetylated in vivo in response to DNA damage" 19 : 1202-1209, 1999

3 "p300/CBP-mediated p53 acetylation is commonly induced by p53-activating agents and inhibited by MDM2" 20 : 1331-1340, 2001

4 "hSIR2SIRT1 functions as an NAD-dependent p53 deacetylase" 107 : 149-159, 2001

5 "Tumor-selective action of HDAC inhibitors involves TRAIL induction in acute myeloid leukemia cells" 11 : 77-84, 2005

6 "Three proteins define a class of human histone deacetylase related to yeast Hda1p" 96 : 4868-4873, 1999

7 "Therapeutic exploration of the p53 pathway" 8 : 38-42, 2002

8 "The human histone deacetylase family" 262 : 75-83, 2001

9 "The emerging role of class II histone deactylase" 79 : 339-348, 2001

10 "The effect of functional inactivation of TP53 by HPV-E6 transformation on the induction of chromosome aberration by gamma rays in human tumor cells" 151 : 385-390, 1999

11 "The 53 gene as a modifier of intrinsic radiosensitivity:implication for radiotherapy" 40 : 197-223, 1996

12 "Susceptibility and radiosensitization of human glioblastoma cells to trichostatin A,a histone deacetylase inhibitor" 62 : 1348-1354, 2004

13 "Role of p53 status in chemosensitivity determination of cancer cells against histone deacetylase inhibitor sodium butyrate" 115 : 11-18, 2005

14 "Role of class I and Class II histone deacetylases in carcinoma cells using siRNA" 310 : 529-536, 2003

15 "Role of caspases and p53 in the apoptotic response triggered by histone deacetylase inhibitors trichostatin-A" 278 : 12579-12589, 2003

16 "Regulation of p53 stability by mdm2" 387 : 299-303, 1997

17 "Regulation of p53 localization" 268 : 2779-2783, 2001

18 "Potential of adenoviral p53 gene therapy and irradiation for the treatment of malignant gliomas" 19 : 1041-1047, 2001

19 "Oncoprotein mdm2 is ubiquitin ligase E3 for tumor suppressor p53" 420 : 25-27, 1997

20 "Negative control of p53 by Sir2α promotes cell survival under stress" 107 : 137-148, 2001

21 "Multiple lysine mutations in the C-terminal domain of p53 interfere with MDM2-dependent protein degradation and ubiquitination" 20 : 9391-9398, 2000

22 "Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1" 242 : 540-547, 1998

23 "Leptomycin B inactivates CRM1/expotin 1 by covalent modification at a cystein residue in the central conserved region" 96 : 9112-9117, 1999

24 "Inhibitors of histone deacetylases induce tumor-selective apoptosis through activation of death receptor pathway" 11 : 71-76, 2005

25 "Induction of caspase-3 protease activity and apoptosis by butyrate and trichostatin A(inhibitors of histone deacetylase)dependence on protein synthesis and synergy with a mitochondrial/cytochrome c-dependent pathway" 57 : 3697-3707, 1997

26 "Histone deactylases:unique players in shaping the epigenetic histone code" 983 : 84-100, 2003

27 "Histone deacetylases and cancer:Causes and therapies" 1 : 194-202, 2001

28 "Histone deacetylase inhibitors:inducers of differentiation or apoptosis of transformed cells" 92 : 1210-1216, 2000

29 "Histone deacetylase inhibitors in programmed cell death and cancer therapy" 25 : 552-563, 2005

30 "Histone deacetylase inhibitors differentially stabilize acetylated p53 and induce cell cycle arrest or apoptosis in prostate cancer cells" 2005

31 "Histone deacetylase 4 interacts with 53BP1 to mediate the DNA damage response" 160 : 1017-1027, 2003

32 "Histone acetylation and chromatin structure and transcription" 389 : 349-352, 1997

33 "Histone Deacetylation in Epigenetics:An attractive target for anticancer therapy" 25 : 261-309, 2005

34 "Genomwide studies of histone deacetylase function in yeast" 97 : 13708-13713, 2000

35 "Evidence for the expression of radiation-induced petetially lethral damage being a p53-dependent process" 76 : 1037-1043, 2000

36 "Enhancement of xenograft radiosenstivity by histone deacetylase inhibitor MS275 and Correlation with histone hyperacetylation" 10 : 6066-6071, 2004

37 "Enhanced radiation-induced cell killing and prolongation ofγH2AX foci expression by the histone deacetylase inhibitor MS-275" 64 : 316-321, 2004

38 "Deacetylation of p53 modulates its effect on cell growth and apoptosis" 408 : 377-381, 2000

39 "Cytoplasmic sequestration of HDAC7 from mitochondrial and nuclear compartments upon initiation of apoptosis" 279 : 51218-51225, 2004

40 "Collaborative spirit of histone deacetylases in regulating chromatin structure and gene expression" 13 : 143-153, 2003

41 "Class II histone deacetylase:Structure,function,and regulation" 79 : 243-252, 2001

42 "Class I histone deacetyalse-selective novel synthetic inhibitors potentially inhibit human tumor proliferation" 10 : 5271-5281, 2004

43 "Chemical agents that promote chromatin compaction radiosensitize tumour cells" 77 : 1033-1042, 2001

44 "Caspase-mediated specific cleavage of human histone deacetylase 4" 13 : 34537-34546, 2004

45 "Activation of p53 in cervical carcinoma cells by small molecules" 97 : 8501-8506, 2000

46 "Acetylaton of p53 augments its site-specific DNA bind both in vitro and in vivo" 101 : 2259-2264, 2004

47 "Acetylation of p53 inhibits its ubiquitination by mdm2" 277 : 50607-50611, 2002

48 "Accumulating active p53 in the nucleus by inhibition of nuclear export:a novel strategy to promote the p53 tumor suppressor function" 253 : 315-324, 1999